BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) represents European small and medium-sized biotech companies involved in developing innovative products to tackle antimicrobial resistance, including preventative and curating therapies, and diagnostic tests.
BEAM gives its members a unique voice to propose and support policies and incentives in antimicrobial research and development in Europe.
BEAM recommends bold incentives that warrant action by policymakers to stimulate much needed innovation.

BEAM Alliance

Org chart

Teams

Offices